CRO · Private company
Labcorp Corporation of America Holdings, Inc
Track this companyFree. Adds Labcorp Corporation of America Holdings, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials111 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- OmniSeq TestLung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of ProclarixRECRUITING · started Apr 3, 2026ClinicalTrials.gov NCT07543757 · fetched Nov 12, 2026
- EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerPHASE1_PHASE2 · UNKNOWN · started Jun 1, 2023ClinicalTrials.gov NCT05498389 · fetched Nov 12, 2026
- Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection KitCOMPLETED · started Apr 17, 2023ClinicalTrials.gov NCT06008457 · fetched Nov 12, 2026
- iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female SubjectsPHASE1 · TERMINATED · started Jan 19, 2023ClinicalTrials.gov NCT05740280 · fetched Nov 12, 2026
- A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)PHASE1 · COMPLETED · started Jul 13, 2022ClinicalTrials.gov NCT05511558 · fetched Nov 12, 2026
- EMB-01 in Patients With Advanced/Metastatic Gastrointestinal CancersPHASE1_PHASE2 · UNKNOWN · started Oct 21, 2021ClinicalTrials.gov NCT05176665 · fetched Nov 12, 2026
- Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 AlterationsPHASE1_PHASE2 · WITHDRAWN · started Oct 1, 2021ClinicalTrials.gov NCT05222165 · fetched Nov 12, 2026
- Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemiaPHASE2 · WITHDRAWN · started Sep 20, 2021ClinicalTrials.gov NCT04938635 · fetched Nov 12, 2026
- PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineCOMPLETED · started Apr 19, 2021ClinicalTrials.gov NCT05697198 · fetched Nov 12, 2026
- Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and HyperkalaemiaCOMPLETED · started Oct 23, 2020ClinicalTrials.gov NCT04566653 · fetched Nov 12, 2026
- First-in-Human (FIH) Clinical Study of NM8074 in Healthy Adult VolunteersPHASE1 · COMPLETED · started Aug 12, 2020ClinicalTrials.gov NCT05642546 · fetched Nov 12, 2026